BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immunoglobulin Class Switching

Below is an extended Immunoglobulin Class Switching patents listing. Click here to return to the Immunoglobulin Class Switching main in depth entry.

Patents :

US Patent No.Title
6994857 Albumin fusion proteins
7129048 Loop probe hybridization assay for polynucleotide analysis
7135278 Method of screening for therapeutics for infectious diseases
7141547 Albumin fusion proteins comprising GLP-1 polypeptides
7141656 MHC complexes and uses thereof
7163797 50 human secreted proteins
7169925 Indole derivatives as interleukin-4 gene expression inhibitors
7175838 Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10
7189690 Albumin fusion proteins
7189820 Antibodies against tumor necrosis factor delta (APRIL)
7122343 Methods to alter levels of a DNA repair protein
7091315 Protein HDPBQ71
7091037 DNA encoding a DNA repair protein
7026447 53 human secreted proteins
7030219 B7-DC, Dendritic cell co-stimulatory molecules
7033590 Factor IX/factor IXa activating antibodies and antibody derivatives
7037700 Regulation of human ceramide kinase
7041871 Transgenic non-human animals capable of producing heterologous antibodies
7074902 Antibody specific for a DNA repair protein
7074904 MHC complexes and uses thereof
7074905 Soluble MHC complexes and methods of use thereof
7084260 High affinity human antibodies and human antibodies against human antigens
7090843 Recombinant anti-CD30 antibodies and uses thereof
7196164 Secreted protein HHTLF25
7208581 TRAF family proteins
7368106 Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
7368527 HADDE71 polypeptides
7368531 Human secreted proteins
7371392 Cd40 ligand adjuvant for respiratory syncytial virus
7371572 Mouse titers after two immunizations with VLPs alone
7381800 Antibodies to HBIMF63 polypeptide
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10
7410975 Small molecule toll-like receptor (TLR) antagonists
7411051 Antibodies to HDPPA04 polypeptide
7429644 Humanized anti-LT-.beta.-R antibodies
7361331 Plant bioreactors
7335489 Polynucleotides encoding a protein kinase C inhibitor protein and methods of using these polynucleotides
7317090 Antibodies to Interleukin-4 receptors and uses thereof
7226747 Method of identifying substances which modulate interleukin 4(IL-4) signaling
7238660 Albumin fusion proteins
7238667 Albumin fusion proteins
7255854 Use of lymphotoxin-.beta. receptor blocking agents for the treatment of antibody mediated immunological diseases
7271156 Immunostimulatory nucleic acids
7279161 Factor IX/factor IXa activating antibodies and antibody derivatives
7279555 Advanced antigen presentation platform
7297336 Factor IXa specific antibodies displaying factor VIIIa like activity
7306919 Antigen-antibody cancer recognition system
7309492 Soluble lymphotoxin-.beta. receptors as therapeutic agents for the treatment of systemic lupus erythematosus
7429645 Humanized anti-lymphotoxin beta receptor antibodies
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional